fertavid
merck sharp & dohme b.v. - follitropin beta - infertility; hypogonadism - sex hormones and modulators of the genital system, - in the female:fertavid is indicated for the treatment of female infertility in the following clinical situations:anovulation (including polycystic ovarian disease, pcod) in women who have been unresponsive to treatment with clomifene citratecontrolled ovarian hyperstimulation to induce the development of multiple follicles in medically assisted reproduction programs [e.g. in vitro fertilisation/embryo transfer (ivf/et), gamete intra-fallopian transfer (gift) and intracytoplasmic sperm injection (icsi).in the male:deficient spermatogenesis due to hypogonadotrophic hypogonadism.
amoxil tablets
kievmedpreparat pjsc - amoxicillin (amoxicillin trihydrate) - tablets - 500mg
amoxil tablets
kievmedpreparat pjsc - amoxicillin (amoxicillin trihydrate) - tablets - 250mg
azitrox powder for oral suspension
pharmstandard-leksredstva jsc - azithromycin (azithromycin dihydrate) - powder for oral suspension - 200mg/5ml
streptomycin sulfate powder for solution for i/m injection
"sintez" ojsc - streptomycin (streptomycin sulfate) - powder for solution for i/m injection - 1000mg
cpg 312 gel breast implant cohesive iii, low height, moderate plus profile
implicor 50mg/7.5mg tablets film-coated
les laboratoires servier industrie - metoprolol (metoprolol tartrate), ivabradine (ivabradine hydrochloride) - tablets film-coated - 50mg+ 7,5mg
tzarevet x mint flavour
cts chemical industries ltd, israel - calcium carbonate - chewable tablets - calcium carbonate 500 mg - calcium carbonate - calcium carbonate - antacid
tzarevet x melon flavour
cts chemical industries ltd, israel - calcium as carbonate - chewable tablets - calcium as carbonate 500 mg - calcium carbonate - calcium carbonate - antacid
eliquis 2.5 mg
pfizer pharmaceuticals israel ltd - apixaban - film coated tablets - apixaban 2.5 mg - apixaban - apixaban - prevention of venous thromboembolic events (vte) in adult patients who have undergone elective hip or knee replacement surgery.prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (nvaf), with one or more risk factors, such as prior stroke or transient ischaemic attack (tia); age≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (nyha class ≥ ii).treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults.